CervoMed Inc. (CRVO)
NASDAQ: CRVO · IEX Real-Time Price · USD
15.95
+0.02 (0.13%)
Jul 12, 2024, 4:00 PM EDT - Market closed

CervoMed Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2007
Revenue
7.140000
Upgrade
Gross Profit
7.140000
Upgrade
Selling, General & Admin
6.522.147.456.444.83
Upgrade
Research & Development
8.441.348.59.436.62
Upgrade
Other Operating Expenses
008.730.10.1
Upgrade
Operating Expenses
14.963.4824.6815.9711.55
Upgrade
Operating Income
-7.81-3.48-24.68-15.97-11.55
Upgrade
Interest Expense / Income
00000
Upgrade
Other Expense / Income
-5.642.33-0.14-0.11-0.09
Upgrade
Pretax Income
-2.17-5.8-24.54-15.86-11.47
Upgrade
Income Tax
00-0.44-1.680.33
Upgrade
Net Income
-2.17-5.8-24.1-14.19-11.8
Upgrade
Preferred Dividends
0001.950
Upgrade
Net Income Common
-2.17-5.8-24.1-16.14-11.8
Upgrade
Shares Outstanding (Basic)
31110
Upgrade
Shares Outstanding (Diluted)
31110
Upgrade
Shares Change
413.65%-60.08%80.83%702.68%106.84%
Upgrade
EPS (Basic)
-0.82-11.20-18.57-22.50-132.00
Upgrade
EPS (Diluted)
-0.82-11.20-18.57-22.50-132.00
Upgrade
Free Cash Flow
-7.45-2.57-14.5-13.55-9.86
Upgrade
Free Cash Flow Per Share
-2.80-4.96-11.17-18.88-110.25
Upgrade
Gross Margin
100.00%----
Upgrade
Operating Margin
-109.35%----
Upgrade
Profit Margin
-30.40%----
Upgrade
Free Cash Flow Margin
-104.27%----
Upgrade
EBITDA
-2.17-5.8-24.45-15.76-11.37
Upgrade
EBITDA Margin
-30.40%----
Upgrade
Depreciation & Amortization
000.090.10.1
Upgrade
EBIT
-2.17-5.8-24.54-15.86-11.47
Upgrade
EBIT Margin
-30.40%----
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).